XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 106,325 $ 45,917
Marketable securities, available for sale 1,598 44,363
Prepaid expenses and other current assets 1,502 2,697
Total current assets 109,425 92,977
Property and equipment, net 78 98
Other non-current assets 867 1,086
Total assets 110,370 94,161
Current liabilities:    
Accounts payable 5,241 6,362
Accrued expenses 3,176 9,330
Total current liabilities 8,417 15,692
Non-current liabilities:    
Long-term debt, net of discount 29,772 29,435
Restricted stock repurchase liability 0 2
Total liabilities 38,189 45,129
Commitments and contingencies (see Note 12)
Stockholders' equity:    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of June 30, 2023 and December 31, 2022; no shares issued or outstanding as of June 30, 2023 and December 31, 2022, respectively 0 0
Common stock, $0.0001 par value; 500,000,000 shares authorized as of June 30, 2023 and December 31, 2022, respectively; 42,420,139 and 23,345,115 shares issued as of June 30, 2023 and December 31, 2022, respectively; 42,381,952 and 23,312,529 shares outstanding as of June 30, 2023 and December 31, 2022, respectively 4 2
Additional paid-in capital 249,668 199,492
Accumulated other comprehensive loss (2) (161)
Treasury stock, 38,187 and 28,641 shares as of June 30, 2023 and December 31, 2022, respectively; at cost (54) (35)
Accumulated deficit (177,435) (150,266)
Total stockholders' equity 72,181 49,032
Total liabilities and stockholders' equity $ 110,370 $ 94,161